Self-Care During Cancer Treatment: Practical Tips for Patients
Featuring: Thanos Kosmidis, Co-founder and CEO at CareAcross
In short
Thanos Kosmidis, co-founder and CEO of CareAcross, walks cancer patients and caregivers through practical self-care strategies covering nutrition, exercise, health data sharing, and taking part in medical research. The session emphasizes that self-care is built on education, personalization, and working alongside your healthcare team — not on rigid rules or perfect diets. Evidence-based self-care can improve quality of life, help manage treatment side effects, and give patients a genuine sense of control over their health.
- •Aim for 150 minutes of moderate aerobic activity per week (in sessions of at least 10 minutes) and two 30-minute resistance training sessions per week — but check with your doctor first, especially if you have bone metastasis or other limitations.
- •Use the Mediterranean diet as a flexible starting point: emphasize whole grains, vegetables, fruits, and moderate fish and poultry while limiting saturated fats — then personalize it based on your cancer type, treatment, weight, and side effects with help from a cancer dietitian.
- •Before sharing your health data for research, understand who will see it, how it will be stored, and what your consent covers — look for platforms that anonymize or pseudonymize your information.
- •Ask your doctor about clinical trials or research opportunities, and consider patient support groups and digital health services grounded in clinical guidelines to stay informed between appointments.
Watch on Cancer Patient Lab YouTube
Ask anything about this — free, no signup
Instant answers grounded in real guidelines, not the internet.
Brad Power October 15, 2025 “What is self care? A theoretical framework for self care is built on a couple of pillars. First of all, it's about getting the right education about what it means when you have cancer, to take care of yourself. Interacting with both mechanisms of action, but also all your tools. Nutrition is a tool, perhaps physical activity is another tool.
Then through that, get some self control towards the disease, some self reliance; become controlled in terms of how cancer affects you. ” – Thanos Kosmidis “There are many people who come to us … asking about a diet: ‘We want to have a list of what to eat in the morning, in the afternoon and evening,’ be it for preventing cancer, if that's the case, or for staying strong with cancer. We feel this is really hard for two reasons.
One is that even if there is such a perfect diet, having it and then adhering to it is a very different story. But it also depends on the circumstances of each individual. We prefer to have in mind some sort of guidelines and directions around nutrition and then around the diet.
Meeting Summary
Patients who have been diagnosed with cancer face confusion and being overwhelmed at navigating many decisions and finding services, including on their quality of life, nutrition, and self-care interventions. Thanos Kosmidis, Co-founder and CEO at CareAcross, is uniquely qualified to lead a discussion on the non-medical challenges that patients and caregivers face and “best practices” for managing cancer care.
He has a background in computer science, telecommunications and business. CareAcross is a global meeting point for cancer patients and caregivers, which supports and empowers them while accelerating oncology research and development. The company has been through the MIT Enterprise Forum and MassChallenge accelerators. They have led four clinical trials, of which one is complete. They presented one at ASCO.
They have been focusing on Europe: UK, Germany, France, Spain, Italy, and Greece. Why should you actively engage in self care activities (such as exercise, diet, and stress reduction) as part of your cancer care?
•Support your overall quality of life, health, and well-being, including your immune system and microbiome health; enhance your physical (e.g., heart and bone), cognitive, and emotional health
•Increase your resilience against disease
•Increase your resilience against treatments; reduce your cancer symptoms and side effects, assist with pain control
•Control your weight, such as malnutrition or weight gain
•Feel a sense of agency and control, that you are doing something to affect your health, better understand your symptoms and side effects, improv improve your psychological well- being, better relations with your doctors How should you engage in self care activities (such as exercise, diet, and stress reduction) as part of your cancer care?
•Educate yourself: find out what you can do to help yourself, types of interventions, understand the standard guidelines
•Personalize: modify your activities to reflect your age, weight, specific cancer diagnosis, and current health condition
•Consult with healthcare professionals : review the plan, make sure you consider any risks, especially if you have specific limitations like bone metastasis or side effects
•Implement: follow your program of behavior change interventions, manage your symptoms, develop self-control and self-reliance, get emotional support What exercise guidelines should you consider for your cancer care?
•Aerobic activity: the recommended standard guideline is 150 minutes of moderate- intensity activity per week; can be vigorous-intensity activity for half that time; minimum of 10-minute sessions; activities that make you sweat and elevate your heart rate
•Resistance training : the recommended standard guidelines is two strength training sessions per week, about 30 minutes per session, 4 sets of exercises, 12-15 reps per exercise
•Personalize: modify your exercise program to reflect your age, weight, specific cancer diagnosis, and current health condition.
•Consult with a doctor : to consider risks What dietary guidelines should you consider for your cancer care?
•Follow a balanced diet, with the Mediterranean diet as a good example: restrict saturated fats; eat moderate amounts of fish, poultry, and dairy; emphasize whole grains, vegetables, and fruits
•Personalize your diet, depending on your specific cancer diagnosis, age, weight, treatment, comorbidities, and side effects
•Consult a cancer dietitian for personalized nutrition advice How can you safely store and share your health data?
•Identify the data you want to collect and share (e.g., outcomes, electronic health records, genomics, wearable data)
•Understand how and why your data will be used, who will see your data, how it will be transmitted, and what is included in your consent
•Review the security and data confidentiality measures (anonymized, pseudonymized, or identified) of the data storage platform How can you participate in medical research?
•Capture and share observations about your situation, preferences, and experiences
•Look for clinical trials and research projects using matching services
•Ask your doctor about research opportunities
•Protect your personal information: carefully read consent forms before participating; be aware of privacy, security, and confidentiality guidelines How can you learn more about things you can do for your health when you have cancer?
•Contact Thanos Kosmidis at thanos.kosmidis@careacross.com or see the CareAcross website
•Find and use digital services that provide personalized support based on evidence and clinical guidelines to keep informed
•Talk to peers, participate in patient and caregiver support groups and online communities
•Consult with healthcare experts, e.g., cancer dietitians for tailored nutrition advice, cancer exercise therapists for exercise
•See previous discussions we have had on lifestyle, exercise, nutrition, and stress reduction:
••
•Adding Exercise for Everyday Life and Developing a Medical Device to Personalize Cancer Treatment
•“Exercise as a Countermeasure to Hormone Deprivation Therapy Side Effects and for Bone and Mental Health”
••
•"A Patient’s View on Nutrition, Supplements, Integrative Oncology, and Complementary Therapies"
•
•The information and opinions expressed on this website or platform, or during discussions and presentations (both verbal and written) are not intended as health care recommendations or medical advice by Cancer Patient Lab, its principals, presenters, participants, or representatives for any medical treatment, product, or course of action. You should always consult a doctor about your specific situation before pursuing any health care program, treatment, product or other course of action that might affect your health. For the video recording, please see here. Meeting Notes KEYWORDS Cancer patient lab, personalized services, non-medical challenges, nutrition, physical activity, self-care, health data, medical research, Mediterranean diet, cancer diagnosis, side effects, quality of life, clinical trials, digital health, patient support. SPEAKERS Thanos Kosmidis (93%), Roger Royse (4%), Brad Power (3%) CHAT CONTRIBUTORS Rick Davis, Russ Hollyer SUMMARY Thanos Kosmidis, co-founder and CEO of Care Access, led a discussion of personalized services for cancer patients and caregivers. He discussed the importance of nutrition, emphasizing a balanced diet like the Mediterranean diet, and the role of physical activity, recommending 150 minutes of moderate aerobic activity and two sessions of resistance training per week. He highlighted the significance of self-care, citing a 25% to 90% improvement in side effects. He also addressed the value of sharing health data securely and participating in medical research, noting the need for evidence-based interventions and the challenges of personalizing CareAcross different healthcare systems. OUTLINE Introduction
•Thanos Kosmidis, co-founder and CEO of Care Access, provided an overview of non- medical challenges faced by cancer patients and caregivers and personalized services for their health.
•His company is Care Access which has been focused on cancer for several years.
•Care Access is a digital health company focused on cancer, with a strong evidence base. Nutrition and Cancer
•Nutrition is complex and misinformation abounds.
•A balanced diet, for example the Mediterranean diet, should be a base.
•Adhering to a perfect diet is challenging.
•Individuals need personalized plans.
•Nutrition can impact overall health, resilience against disease, and the prevention of malnutrition and cachexia.
•Every cancer diagnosis is unique, affecting how nutrition impacts the patient.
•Factors like age, weight, height, and specific cancer subtypes influence nutrition needs.
•Treatments, comorbidities, and side effects also play significant roles in nutrition management.
•It is important to consult healthcare professionals for tailored nutrition advice. Exercise and Cancer
•The guidelines for aerobic and non-aerobic activities emphasize the importance of moderate intensity exercise.
•Aerobic activities should total 150 minutes per week, while resistance activities should include two sessions per week.
•Physical activity has benefits on heart health, bone health, cognitive function, and emotional well-being.
•Exercise can help manage cancer-related fatigue and improving overall quality of life. Self-Care and Its Evidence-Based Benefits
•The theoretical framework for self-care includes education, symptom management, and quality of life improvement.
•Self-care depends on behavior change.
•Clinical trials and real-world data showing improvements in side effects and quality of life with self-care interventions. Health Data Sharing and Security
•You can share your health data for medical progress and improved quality of life.
•You need to define, describe, and annotate the data properly.
•You should consent and understand the context of data collection.
•The infrastructure for secure data storage and sharing includes security measures and compliance with regulations. Participation in Medical Research
•Participating in medical research can help scientific progress and provide societal benefits.
•Patient-reported outcomes and experiences are valuable in research.
•Continuous data collection throughout the patient journey is useful.
•Patients should use platforms that provide relevant material and support based on their data. Challenges and Opportunities in Different Healthcare Systems
•Healthcare systems in the US and Europe are different in diagnosis and treatment timelines.
•Patients in different countries have unment needs and access to Centers of Excellence. Hydration and Fatigue Mitigation
•Staying hydrated is important.
•Tips for making water more appealing include adding flavor or avoiding carbonated water. Protein Intake and Cancer Outcomes
•There is a debate around protein intake and its impact on cancer outcomes, for example higher red meat consumption among colorectal cancer patients.
Full transcript
Roger Royse This is the weekly presentation of the Cancer Patient Lab. I'd like to introduce Thanos Kosmidis. He is going to present about providing personalized services for your health and cancer. Thanos is co-founder and CEO of CareAcross. He's going to lead a discussion on non-medical challenges that patients and caregivers face. His background is in computer science, telecommunications, and business.
CareAcross, as I'm sure he'll explain, is a global meeting point for cancer patients and caregivers. Thanos Kosmidis 0:43 I really appreciate the opportunity to share some thoughts with you. We're grateful to Brad and the Cancer Patient Lab for providing this forum. Of course, I'm new to this, in the sense that I haven't participated in these, but I know you have been doing this for a while.
I’m really grateful that you've been doing this for everybody out there. It's really extraordinary what can be done with these media and communications. The company is called CareAcross. It's been focusing on cancer for several years. I won't speak too much about it today. I will talk about it a bit more towards the middle part of the presentation, when it's a bit more relevant and timely.
Some practical – but also in some cases theoretical – frameworks towards tackling day-to-day life with cancer. The disclaimer we just heard is very appropriate. Here you have ours as well. This is not medical advice. We know we don't want to, and we cannot really replace medical advice. It's invaluable. Please speak to your doctors, keep speaking to your healthcare professionals. They're there to help you.
Easier said than done sometimes, but that's what I would do. And thank you for making a note of this. There are some themes in this webinar, and I'll try to stick to them. These are the main topics that we wanted to address here. This will be one-by-one. The first one is nutrition. The second one is touching upon physical activity, and what could be done. How much is recommended? Evidence on self-care.
What does it mean to self care after a cancer diagnosis, and then some discussions on health data and sharing data, but also participating in medical research, really relevant and appropriate, and I would say, quite interesting topics. The first topic is one of the most interesting ones out there. I have to admit that we are always impressed by the amount of information – but also misinformation – about nutrition.
Nutrition is a notoriously hard topic to study and generate evidence for, so it is no wonder that there's so much out there in terms of trial and error, but also understanding what can be done around that when it comes to nutrition, then nutrients, and food and diet.
I'm sure you've read more than your fair share of blog posts and articles and peer-reviewed publications, but essentially one topic that we also have found very interesting and very relevant is, what does it mean for each individual? There are many people who come to us as an online free service asking about a diet. But also it really depends on the circumstances of each individual. That's what the evidence shows.
A balanced diet can generally help. There are numerous types of balanced diets. One of the most relevant ones, and maybe also applicable in this case, not that this means that this is helpful or not in cancer, is a Mediterranean Diet.
Even adhering to this can be a challenge, because it talks about a low intake of saturated fats, moderate intake of fish, poultry, dairy, mainly yogurt and cheese, as it says here, but also high intake of whole grains, veggies, fruits, and others. This is probably easier said than done. I have to say that I don't even know how many of these are applicable or adhered to in the Mediterranean itself.
Maybe we can call it something else, but beyond that tongue in cheek, it's also a matter of keeping it in a balanced manner. And there are a lot of discussions out there. There's a lot of expertise as well. There are oncology dietitians who are very familiar with this, and they can help you tailor. You know what you could do in terms of keeping a balanced diet specifically for your case. Why is that important? What is the impact of nutrition?
We pretty much all know about this. First of all, overall health and well being. We know how it feels when we're not nourished properly. We generally know how it feels when we are diagnosed with a disease like cancer. Staying resilient against the disease is something that nutrition definitely helps, both on a macro and a micro scale. Both are important when we receive treatments. These are not necessarily easy treatments.
You would probably say the opposite. These are very challenging ones. Staying resilient and actually being able to withstand the treatment, but also make the most of it. If we look at it from a molecular level, going a bit further in the molecular realm, and the more biological aspects of this microbiome, if only we had what a penny for its time. We read about this recently, very interesting stuff.
There is not enough evidence right now, but we do know that there is an impact of the nutrition, of course, on the microbiome, but also of the microbiome towards the overall health and well being and the overall conditioning.
If you go a bit more tactical and a bit more tangible, then it does have an impact on weight control, and that could be in both directions, losing weight or gaining weight, depending on the situation and specifically in the prevention of malnutrition and cachexia.
Cachexia is that condition which is a combination of various factors, but essentially it's unintentional weight loss, and it is, after some point, irreversible, and in some cases, it is a major risk for the patient's life, as you can imagine. Last but not least, we want to have a long and high quality of life ahead of us, so this is really an investment in that long term survivorship, hopefully that will see us keeping cancer behind us.
We have to realize, recognize, and acknowledge that we're not the same. Every patient is unique. So what are some key factors to consider when thinking about our own case in terms of nutrition, but also when looking at what we're reading from the science, the literature, even the random blog post about nutrition and cancer? First of all, diagnosis. We're talking about cancer diagnosis in this case.
But every diagnosis is different, even the sub-type of diagnosis. A common example is hormonal breast cancer, as opposed to non-hormonal breast cancer. There are very different aspects there that affect the way that nutrition affects us. Of course, there are lab tests and other metrics that are relevant to us.
So it's important that we know these tests, and we keep a tab, and we, of course, follow the recommendations, and of course, age, as well as weight and height. There's a whole discussion, even on the value of body mass index. I don't see too much point in getting into that right now, but essentially understanding the specifics of each individual body at the end of the day. It's not necessarily clear how genetics affects all of this.
There are some indications, but not necessarily at the level of evidence that you know would be actionable, but it is something to keep in mind. ” But of course, you know that weight does change, age does, unfortunately change, at least in a predictable manner, the treatments that we're receiving. What kind of treatments are we getting for cancer?
This is very relevant, and it affects a lot how ther factors or either counterbalance that, or, support the impact of our treatments. There are clearly comorbidities. It is rare that people have only one condition, especially as we grow older. Especially with chronic conditions, this is something that we need to take into consideration. A key example here is diabetes. Maybe one in 10 people out there have diabetes that's actually diagnosed.
So how do we address this? Easier said than done. Thankfully, with diabetes, there are some directions from the science of the evidence. And of course, we should not forget not only that all of these affect our quality of life and our side effects, adverse events, especially during active treatment, but also nutrition does affect side effects in both ways, positively and negatively.
There are many nutritional tips that are applicable on specific side effects, and we've seen them work. They're part of a lot of clinical guidelines out there as well. So some of the factors are here. All of these then tie into the priorities and preferences of each individual. The least of those could be, for instance, what kind of food you prefer, what kind of ways you want to eat.
But also, if we have some specific limitations or specific preferences, be it for religious or other reasons. Every patient is definitely unique, also in terms of nutrition and how it affects the cancer journey. A lot of questions, right? All of these factors, do we have the answers? Are we there yet? You probably guessed the answer to that question.
gov, about clinical trials that are active, either recruiting or not, but are active, not completed yet, around the condition of cancer, any cancer, and nutrition. I think the exact number is around 1800, so close to 2000 trials that are active right now, and I bet several thousand that have been completed and may have interesting results. So probably we're not there yet. We're still asking some questions.
We're still trying to understand all of those interactions. What about the research that has been going on, be it clinical or otherwise? There is an estimate out there that there's about 25,000 manuscripts published in peer-reviewed journals since 2011 only. So that's quite a lot. No wonder we can not be confused, but just in terms of, structuring this, a lot of this is about prevention. How does nutrition help prevent cancer, or the opposite?
In terms of, how could it help cancer progress? Biological mechanism of nutrition, its role in supportive and survivorship care, but also in terms of public health. I'm sure you have your own examples of what we've seen in the public health domain that could be applicable in nutrition, which could be relevant to cancer in general. "How to Care for You s Kosmidis) What about the research that has been going on, be it clinical or otherwise?
So that's quite a lot. I will now shift to physical activity and exercise. Sometimes they go hand-in-hand with nutrition. Not necessarily, but is a quote, unquote “consensus” right now among those guidelines from scientific communities around the world which have been studying this for a while. From the left hand side, we're talking about aerobic activity.
These are the things that make you sweat, make you breathe heavily, that have your heart rate elevated a bit more. So the guideline, or the direction of the guidelines, talks about 150 minutes of moderate intensity activity per week. This is not too much. This is something like maybe two-and-a-half hours of moderate intensity activity. This could be vigorous, anti-intensity activity, if it's half of that, or essentially an equivalent combination.
We want to have at least 10 minutes at a time. We want to break a sweat. Essentially, we want to be able to be active. If you go beyond those guidelines, it probably helps. Clearly, some examples, you can read them on the slide. It depends. Your mileage may vary. Your preference will vary, for sure, and that's a good thing. But getting out there is useful, and there is the evidence there that it helps cancer patients as well.
Looking at the right side of the slide, we're talking about non-aerobic activity. This is resistance training, strength training. The guidelines talk about two such sessions per week. What does it mean to have a session of those? What does it mean to have a day of strength training? It's perhaps maybe 30 minutes, or maybe up to four sets of exercise, to 15 reps per exercise. Nothing really drastic here.
You don't have to spend your day at the gym or buy a lot of equipment. You have some resistance training machines, some weights. Body weight exercises are key. Some of the people who used to go to the gym during Covid times, they use their body weight at home, and they use that instead. These are the guidelines. This is what the evidence points to. Importantly, not everybody, including clinicians, is or is expected to be aware of these guidelines.
They're there. They're from scientific societies that we all at least respect and perhaps trust, but they are important to actually read through and hopefully follow. Again, each patient is unique. We looked at the guidelines, but the implementation of those guidelines will probably vary at the individual level quite a bit. Would you do the same things if you're 35 or you're 85? Maybe it depends. Weight does matter. Your age matters.
As we said, it’s very important to keep an eye on those specific diagnoses. For example, if somebody has bone metastasis, bone metastasis in general is quite challenging, but because of the structure of bones and how they affect exercise, it is pretty critical. Getting your doctor's view and opinion and approval is definitely true if this is cancer that we're talking about.
How active we've been, how emotionally well we feel, our comorbidities, as mentioned before, but also, what else is going on in terms of side effects. Adverse events are the things that are affecting our day-to-day life. You cannot really lift weights that easily when you have peripheral neuropathy. Lymphedema is a challenge. Ostomies is another practical one, and so on and so on. Many challenges that each patient out there is more familiar with.
Talking to your doctor is of great value here, as well. Beyond those benefits that we talked about, there is an overall conditioning benefit, and our heart health and bone health is improved. This is quite clear from what is out there. There is increasing evidence about the brain function improvement and also some of those cognitive impairment challenges that we face as we grow older. Of course, emotional well being.
Last, but definitely not least, there is a sense of agency and sense of control. It's very important to be able to do something about your day-to-day life that does not include going to the doctor. It does not include getting medication. That does not include sitting down and getting lab tests. You do something for yourself. Hopefully you're feeling better about it, not necessarily, very easily, not necessarily at the start.
Importantly, exercise is also part of the evidence and the guidelines for some of those specific side effects of cancer and its treatments. Importantly, exercise, physical activity, is quite well evidenced to support cancer-related fatigue. And of course, it's that oxymoron. When somebody is really fatigued and really drained and they cannot really have the ability to move as much, getting them to actually move physically is a challenge.
That's where all those behavior change mechanisms come into play, and it's very hard to implement. But from what the evidence states, it's actually worth it. Easier said than done, all of this. Definitely speak to your doctor, and definitely keep in mind that the benefits go beyond today, go beyond cancer, and that's a good thing, switching into self care.
If we broaden that topic, what's the evidence out there regarding self care, in cancer support? Among many of us self care would be something quite well defined, but not necessarily. We all believe we're caring about ourselves. What does self care mean? How is it different from what we do day-to-day? This is where it's most relevant to describe what CareAcross does.
This is a very brief introduction, not intending to bore you with details or marketing mumbo jumbo. We are a digital health company. We've been focusing on cancer since day one. We've been around for 12 years now. We are quite evidence-oriented. A lot of strength in the medical oncology field, a lot of strength in the technology aspects, some of those logos, which we're happy to be associated with one way or another.
We also have a lot of scientific guidance from our scientific committee, excellent experts from all over the world, who have been out there with us and providing us some direction, but also level setting on what's possible and what's important. We have been doing our own research and development. We are running our randomized control trials. We have completed one on advanced metastatic, non-small-cell lung cancer.
We presented those both last year in 2024 that was the interim results and the final results were presented in Chicago in June of 2025. The results showed a positive impact on both quality of life side effects, but also healthcare costs, very important. Let's not forget those. But also, we have enrollment ongoing on similar trials in breast cancer, multiple myeloma, and sarcomas, so a very diverse R&D program for our company.
Back to that question: What is self care? It's not something we can eliminate, but it is a tool that we have beyond this. Then the impact is shaped around some aspects of symptom management. When there is a symptom, when there is a side effect, to prevent it sometimes, but also manage it throughout the patient journey, improving the quality of life based on that.
As you know quite well, the quality of life of an individual is a very broad and hard-to-define aspect, but it definitely, for example, includes emotional health, one way or another. Getting that addressed, those interventions for self management: what are those things that we need to change? We need to do an intervention.
For example, if I should get my 10,000 steps, or whatever the case may be, every day, or get those 150 minutes of aerobic activity every week. That's something that is an intervention that requires behavior change. It's very hard to get self care without behavior change. We need to do something about this.
We need to change how we were to something that we believe and maybe our clinician also provides direction towards that can help us regarding cancer through that self care mechanism. What evidence do we have then? What do we know about self care? We had some examples of food and physical activity. What do we know about these adverse events?
Current evidence does talk about how it helps to manage adverse events, just by having better knowledge of this, even by understanding why it happens and how common it is, and perhaps what is a possible way of addressing it, then pain control. Sometimes this is also possible, not all of the time. Of course, we cannot play God, but that can help.
Psychological well being is something that each of us is trying to do with self care every single day with a cancer diagnosis is harder, but it's probably more impactful when we get it, quote, unquote, “right”. Of course, all the aspects of physical, cognitive, and emotional functioning actually have a much better control of our day-to- day, last but not least, when we take care of ourselves.
We have attained, or we can attain a better quality of care. This means that an overall quality of care that means including our healthcare professionals, the healthcare ecosystem, the supportive tools and mechanisms that we have in our disposal, trusting our doctors and being self efficacious when it comes to using those resources, using ourselves, using our time, using those tools to bring about those benefits. Again, easier said than done.
From a CareAcross perspective I already mentioned that we have been running some clinical studies, but also we have a lot of real world evidence from our own web platform. As an aside, we run online platforms that cancer patients, and in many cases healthcare professionals or oncologists, perhaps, or hematologists use, and patients engage with those platforms, and they receive very personalized support that's based on evidence.
We have our own data that shows that there is a benefit from these self care support mechanisms, self care interventions. Back in 2021 we had submitted and got the approval to share this information about how much the side effects of patients improve when they're using our remote system symptom management platform. The impact ranges from 25% something to almost, I don't know, 90% perhaps, yes, even 90%.
How much do patients improve as they're using our services? And this was a fairly sizable sample of patients. There are more than 2200 patients from eight countries. Quite interesting. And quite impactful. We drilled down.
The year after that, we tried to understand how all of these interventions that we have in place, for example, affect cancer-related fatigue, which is by our measures the most common side effect of cancer and its treatments – high prevalence and also quite resistant to change. We plotted, we did a lot of analysis, and we noticed that there are some combinations of interventions that work better than others.
All of these patients receive information and tips about physical activity because it's the best set of evidence that we have. Then things like hydration, food timing, relaxation exercises and even a fatigue diary, understanding when you feel most fatigue, these were correlated, associated with a better improvement in cancer-related fatigue.
Having those tools at your disposal, very simple things, nothing spectacular, nothing expensive, of course, other than everybody's time and attention, which is priceless there. I'll give you some more information about our evidence from our sarcoma trial. This was an abstract from this year's American Society of Clinical Oncology Congress. I believe there are 10 side effects.
Only one did not see a better improvement in the intervention arm of the study. Patients who have been using our services and receiving those supportive mechanisms for self care. This is still a self care mechanism. They feel better with specific side effects that they are reporting on the platform.
That is the final results of the study that has been concluded, the one I mentioned about orally presenting at ASCO this year on advanced non-small-cell lung cancer, whereby we saw that out of the 22 side effects, most of them, there was an improvement. There was a higher improvement in the intervention arm.
If you're actually following those interventions, you get a better quality of life, a better outcome, to be more precise, for those specific side effects. The important thing here is that even reporting and tracking those side effects seems to have a quite positive impact. Even tracking the side effects, even beyond receiving self care interventions, you have 50% or more improvement in symptoms. Quite impressive, one would say there.
But you know, two of those side effects were associated with statistically significant relative improvement, that was rash and stomatitis. Keep in mind, these are advanced, or metastatic, non-small-cell lung cancer patients, not an easy reality for many reasons, but also in terms of side effects. This is a different set of evidence, which shows that when there are those self care interventions, it is not a one-off improvement.
Most of the time, the improvement lasts. So tracking those interventions across the treatment cycles, when there is an initial indication of side effects, most of the times the improvements last long. That was the chapter on self care. We had some insights there, but also some evidence, also from our own company, which I was happy to share.
Switching gears a little bit… How can we use health data to share with others, storing it securely, sharing it properly? We all know the value and importance of health data, so how can we use it? How can this be useful for ourselves and for others? A question could be, why? Why share health data in the first place? Why share? What is the value?
I believe that this audience is probably quite aligned with the notion that more data means more findings, and more findings means more opportunity and more hope for treatments, for improvements in the quality of life, for benefits across the board. So we need to be part of this ecosystem by sharing our health data. Again, there are different levels and different levers for sharing, and this perhaps, is also relevant to the next few slides.
But in terms of practical purposes, of practical aspects, how can we do it securely? What can a patient do to do this securely? The first step is defining what kind of data to collect and store, describing it properly, but also providing the relevant consent, if that is appropriate for that individual patient. Defining the data. Are we talking about patient and broad outcomes? Are we talking about electronic health records?
Are we talking about genomics, genetics, wearable data? All of this is potentially in scope. So let's define the scope. Let's define the source of data. What do we want to do, and what is the aim of the collection of the data and for sharing the data? This is quite well described in the context of, for example, a clinical trial. But as we all know, this is the tip of the iceberg of all those data collection points out there.
So then describing and annotating the data in its context. Data out of context is useful, but not as useful when we know about the context that the data is being collected and then describing the success criteria for actually collecting and sharing the data, how much data is enough, when, what kind of cadence of data collection is there, what's the completeness threshold that we need to reach last.
But definitely, not least, from the patient's perspective, and for many reasons, regardless of where we live, regardless of HIPAA, regardless of GDPR, consenting, understanding and agreeing on what we want to do with our data, because it is the patient data and for what purposes this data will be shared, so deciding and providing the consent which now it becomes more practical depending on where we live or we are, the GDPR versus other HIPAA or otherwise frameworks.
That was the patient side. Now let's talk about the infrastructure, where it could be a platform. It could be a platform like CareAcross. Of course, it could be something else. It could be a public health system, or it could be a private platform. elf When You Have Cancer" That was the patient side. It could be a platform like CareAcross. Of course, it could be something else. Storing it is one topic which is increasingly important.
How this information is processed is very important as well. What kind of information is being processed, what is being left aside, left out if anything, and what level of aggregation, if anything happens? Of course, the last step is the sharing bit. So storing it. Where is the data being stored? Is it stored in the same city, region, country?
The state-by-state issues that we want to keep in mind are the country-by-country, other laws and regulations that, for example, the infrastructure the provider needs to be aware of, and of course, security addressed. This means that when we have a storage solution, what kind of security is in place, processing data that is related within health.
These two bullet points, this part of the slide, could be on a whole, not only a webinar, probably a whole university course. I’m not trying to address this fully here. But what kind of information is being processed? What is the purpose of the processing? Is it anonymized? Is it pseudonymized? Is it identified? What can be done when somebody gets a hold of the outcome of this processing? ”?
This is one example of an important question, not the only example. And of course, Who are we sharing this with? What are we sharing with that organization, with that recipient, in general, but also when we actually share the data, how is it being transited? What kind of security measures are in place to transit the data properly? In the outline we had and the set of questions that we had, this is the last question.
It's a very positive one, if you will, and it's a very useful and valid one as well. We talked about the value of sharing data, and the value of participating in medical research is enormous. Unless there is medical research, there's no medical progress, and we all know what that means. So indeed, participating is necessary for many reasons, for science and for society and community.
If we talk about participation in research that is not in the confines of the structure of a clinical trial, there are many reasons to participate. But in general, we're talking about data. We talked about data before contributing data, contributing those patient-reported outcomes: how I'm feeling, what is my situation, what are my challenges.
” If we are part of a healthcare system, and we were exposed to the healthcare system a lot, those experiences include that healthcare system interaction. In some countries it is mandatory or necessary to collect data about access to the hospital and parking facilities. These are not trivial. These are hard. It is important to engage throughout the patient journey. This is not a one-off data contribution, because cancer is not a one-off story.
It's a chronic condition nowadays. Engaging throughout the patient journey is important. Keep contributing the data. Some of those data exchanges have an outcome, some supportive materials. The more information we have for the patient, the more relevant material we can provide. Every bit of information collected results in relevant material for the patient. So if there is something out there based on the data, you can try to follow.
It may be hard. It may be a behavior change. It may be tricky, maybe counterintuitive. ” It's not, ideally, the kind of material you would read from us, not this simplified and not really appropriate kind of material, but it's there for you. Try to use the platforms that provide you some relevant material when you provide data, provide also some of the context.
It's important for us to have the data in the context that is applicable, so that could be, for example, comorbidities, what other conditions are affecting you, if there are preferences and priorities that affect your patient experience or otherwise. And of course, we alluded to that earlier, security, privacy, confidentiality, these are important. Stay diligent there.
The rules and regulations are out there to protect the patient, first and foremost, and it's important to not be an expert on this as well. But be aware, be careful, at least in terms of how this is being treated, even especially outside of clinical trials. If this is a clinical trial we're talking about, clinical trials are not easy. The framework is quite complicated. Look for those opportunities to talk to your clinician.
Not every trial is applicable to every individual, especially with cancer. Trials of specific criteria, inclusion and exclusion criteria, which may make some patients ineligible, or at least at that time not eligible. Use the tools that are out there. Use the clinical trial registries. Use those matching tools.
If there is a trial that you're interested in, if there's a trial that's being identified, there is an important document, which is the informed consent form. This is the informed consent that you receive to understand what is being meaningless. Take care. We try to read the form if you are to sign it, so that you understand what this entails. This email address, if you want to join those free services. There are links on that bottom slide.
Brad Power
One of the things that Thanos is uniquely qualified to address is European and even Pan- European answers to some of the things that he's been talking about. I'm just curious what differences he sees. He spent time in the US. He spent time in Europe. He spent time working with people across Europe. What are the differences in terms of the challenges and opportunities for the various interventions that you've been describing?
Thanos Kosmidis
As each individual is unique, also its healthcare system and its country is as well, and how it affects patients. Many examples. One example that comes to mind is we asked, I believe it was a few thousand patients across several countries, about their diagnosis and treatment journey.
And for example, how long it took to get to a diagnosis, how long it took after that to start the treatment and there were definitely big differences in different healthcare systems. This is a reality that individuals with cancer are not necessarily ready to address. Another difference was the unmet needs of patients in different countries.
But I will also guess, although I don't have data about this in different regions, people who have more access, of course, to Centers of Excellence, but also to charities and trusts for cancer patients have different levels of access. It's part of that personalization that's key to get the answers right. I hope this gives some sort of insight. Brad Power 47:37 Could you give some examples? Because you were speaking in generalities.
Of course, there are differences. But can you give an example of one country that does something? For example, I've heard that the Netherlands does a really good job of primary care or and then they are very good at rationing care. And maybe Germany is more interested in integrative oncology and so you can get insurance reimbursement for things like going to spas or whatever. Can you tell some stories or give some examples?
Thanos Kosmidis
Some examples which are more anecdotal and come from just just comments from patients. Italy is quite interesting in how diverse their healthcare system is. We know patients who have moved around the country, and they're having trouble reintegrating and getting access to the same level of care for cancer that they've had. They're also very interesting when it comes to sharing data. They're very eager to share data.
They're very open towards that. In terms of the statistics that we had from our analysis of the diagnosis journey and the treatment journey and the timing of that it came to it was not much of a surprise to us that in the UK, there was a substantial gap between the diagnosis and the beginning of treatment, while, for example, in Spain and in Italy, that was much shorter.
It also speaks to both the prevalence of private and public practices and so on. Germany is an interesting example, which is also related to how oncology care is being provided there. I'm not, I'm not a clinician and an expert on Germany at all as well, but there's a lot of site-specific expertise in Germany.
Somebody who has a particular cancer may be seen by an expert in the particular tumor type to tumor site, as opposed to a cancer specialist, depending on the case. It's very interesting and diverse. My most dark difference was actually, come to think of it, the inclination to get the Covid vaccine in the beginning of Covid among cancer patients. There we already have some data about how different countries are more open to that.
I forget the exact statistics, but the difference between the more inclined to the person who was the least inclined was quite, quite stark. Roger Royse 50:35 Rick Davis has a question in the chat about hydration as a mitigation of fatigue. Can you speak to that?
Thanos Kosmidis
That was one of the outcomes of the analysis we did, and what we identified was that there is a correlation of improved mitigation of fatigue for those patients that received tips about hydration. When we talked about that with experts, they realized that this makes a lot of sense. They realize that there is little strong push towards hydration when there is a cancer diagnosis and there is fatigue.
I don't understand the mechanism of action. I know that it's not applicable just to cancer patients, but maybe it's just the simplicity of that tool. Maybe it's just the simplicity of just staying hydrated that made the most difference. I don't have a lot of biological or other explanations to share.
Roger Royse
Generally, I've heard a person should get a liter of water for every 1000 calories, and I suspect it's probably at least that for a cancer patient. Thanos Kosmidis 51:53 The information that we saw when we were building that part of the platform spoke to more. I mean, it was more broadly, around two liters per day. I think there was an indication that if you try to do more without overwhelming yourself, it is even better.
Roger Royse
Many of us do not get enough water, Thanos Kosmidis 52:21 Which is another behavior change, but guidelines do differently. One of the interesting parts of those tips is that you know there's a reason that somebody may not feel like drinking water, especially if they have mucositis or other challenges, and some of those supplementary tips around that is that you could have some flavored water.
Or if there's not, you should avoid carbonated water, for the most part. But if you add some flavor and make it more appealing to yourself, then it's a more palatable – no pun intended – intervention. Roger Royse 53:02 Going back to what you said about nutrition, there's a raging debate, both within cancer and outside of cancer, about protein and how much is appropriate.
We've seen a lot of studies that show higher protein may be correlated with worse results in cancer. Is that true? What do you see? Is this another one of those highly individualized things? Or can we make some generalizations? Thanos Kosmidis 53:34 It's not something I'm strongly involved with in terms of research. I'm not familiar with individual strands of research taking place. I know that it's very controversial, as you said.
Speaking of controversy, which is quite interesting, we have evidence that people who have high BMI, for example, in some cancers have better outcomes. People who are overweight have better outcomes. In some cancers, there is so much context that we're missing in this analysis, unfortunately, that that for us is a big challenge.
One thing I can say in terms of protein which, of course, is one part of the protein sources is that, because we do collect a lot of real world data for patients, I remember, it was a while ago that we did this analysis, and it was specifically for colorectal cancer patients, the average amount of red meat that patients in our group, it was a few 100 patients reported as eating on a weekly basis was definitely higher than what pretty much every diet out there would advocate for.
Is that a good or a bad thing? I'm not the expert to say, but it does speak to what we believe is right and what we see patients are doing. I'm sure there's reasons for that, for the patient. Brad Power 55:43 What are trends in your business? I think you've been at this for a decade or so. What can you say? Are trends one way or the other? Different emphasis, different focus, people having different kinds of challenges?
What trends do you see across the experience? Thanos Kosmidis 56:06 What we do realize is shifting in this kind of activity is the level of evidence that's necessary. A few years ago, proclaiming to the world that, “Hey, we have a health app. ” Or was something that people would start using, and they would play with. Now, there's quite a lot, and we've seen the cycle of apps that essentially don't really make a difference.
I think it's true for every kind of innovation cycle. Now we want to have that level of evidence that showcases and proves that the impact of those innovations is real and when it is applicable. We've seen the more open innovation ecosystem, and then gradually moved into the ecosystem which says you need to have a clinical trial to validate this. In some countries, you need to have specific types of clinical trials to be part of the health system.
In Germany, and increasingly in France and in Belgium and in Spain, there are the digital health formularies. There are lists of digital health apps which manufacturers of apps can get onto by meeting criteria through some clinical trials, and they get reimbursed from the healthcare system, just like a treatment is being reimbursed. We definitely have seen that transition, and we feel this is the right approach.
The challenges remain that if it's a health-related service, it is not enough to be out there. It is not enough to persuade one stakeholder, be they doctors, be they patients. It is a multi-stakeholder challenge. This is true for cancer, especially so we've seen that remain in getting stronger and stronger. So easier said than done, to be out there and making a difference.
And that's why I think that all of the companies like ours that are out there are really competing against inertia. We are really competing against misinformation or lack of information, and we collectively can support, hopefully more and more patients, and with your help and what you're doing to support patients as well, that's very valuable.
Want to learn more about your specific case?
Upload your medical records and ask Navis questions tailored to your diagnosis.